Bio-Rad Labs (BIO) Issues Q3 EPS of $1.61, Beats by 8c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $358.51 -0.74%
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Weighted average common shares - diluted: 29.59M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q3 EPS of $1.61, $0.08 better than the analyst estimate of $1.53. Revenue for the quarter came in at $516.5 million versus the consensus estimate of $511.47 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
- Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
